Home › Companies › BIOGEN INC. › 2023-2024

BIOGEN INC. 2023-2024 Proxy Voting Records

Compiled from SEC Form N-PX filings and BIOGEN INC.’s Form 8-K (Item 5.07 on EDGAR). Page generated 02 October 2026.

25Reported items
877Asset managers
12,275Fund votes
2024-06-20Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore BIOGEN INC. in the interactive database Compare manager voting policies

Official 2023-2024 meeting results reported by BIOGEN INC.

These tallies are BIOGEN INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

BIOGEN INC. — official shareholder meeting results, meeting held 2024-06-20
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Outcome
Elect Director: Caroline D. Dorsa	87,883,981	31,591,984	84,665	--	9,672,399	Majority: yes
Elect Director: Maria C. Freire	100,691,870	18,771,139	97,621	--	9,672,399	Majority: yes
Elect Director: William A. Hawkins	95,931,549	23,539,595	89,486	--	9,672,399	Majority: yes
Elect Director: Susan K. Langer	92,603,948	26,870,919	85,763	--	9,672,399	Majority: yes
Elect Director: Jesus B. Mantas	99,615,562	19,856,501	88,567	--	9,672,399	Majority: yes
Elect Director: Monish Patolawala	119,078,211	388,227	94,192	--	9,672,399	Majority: yes
Elect Director: Eric K. Rowinsky	96,514,372	22,954,348	91,910	--	9,672,399	Majority: yes
Elect Director: Stephen A. Sherwin	101,152,837	18,318,068	89,725	--	9,672,399	Majority: yes
Elect Director: Christopher A. Viehbacher	118,593,483	886,743	80,404	--	9,672,399	Majority: yes
Proposal 2: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast as follows:	123,728,418	5,348,316	156,295	--	--	Majority: yes
Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:	114,367,799	5,054,473	138,358	--	9,672,399	Majority: yes
Proposal 4: Stockholders approved the amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast as follows:	103,146,578	16,274,796	139,256	--	9,672,399	Majority: yes
5. Stockholders approved the adoption of the Biogen Inc.	112,726,169	6,693,956	140,505	--	9,672,399	Majority: yes
6. Stockholders approved the adoption of the Biogen Inc.	119,064,435	413,475	82,720	--	9,672,399	Majority: yes

Source: BIOGEN INC., Form 8-K — read the filing on EDGAR.

How asset managers voted at the BIOGEN INC. 2023-2024 meeting

Each item below shows how the 877 asset managers that disclosed a BIOGEN INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of BIOGEN INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Say on Pay - To hold an advisory vote on executive compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 10 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 114,367,799AGAINST: 5,054,473

BIOGEN INC.’s own tally for this item (“Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”): 114,367,799 for, 5,054,473 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 79% for, 3% against (82% of the company cast a for/against vote).

The 812 asset managers below cast 97% of the shares they voted on this item FOR. Fund share totals are not shown for this item: fund-reported shares overlap across filings (an adviser and the funds it manages can each report the same shares), and here their sum exceeds the total votes cast at the meeting.

FOR 97%

FOR: 97.4%AGAINST: 2.6%ABSTAIN: 0.0%NOT VOTED: 0.0%UNKNOWN: 0.0%

Largest asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	34,062,021	0	For
PRIMECAP MANAGEMENT CO/CA/	15,773,607	0	For
BlackRock	11,546,092	0	For
T. Rowe Price	11,322,370	0	For
State Street	5,928,299	0	For
Wellington	5,019,456	0	For
Fidelity	5,010,005	0	For
GEODE CAPITAL MANAGEMENT, LLC	3,429,316	0	For
Invesco	2,334,914	0	For
PRIMECAP Odyssey Funds	2,212,789	0	For
Charles Schwab	1,739,931	0	For
VAN ECK ASSOCIATES CORP	1,650,355	0	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,646,710	0	For
Beutel, Goodman & Co Ltd.	1,541,150	0	For
Clearbridge Investments, LLC	1,539,243	0	For
Northern Trust	1,370,962	2,988	For
American Century	1,272,852	0	For
Jackson National	1,112,823	0	For
Dimensional	1,062,001	0	For
MELLON INVESTMENTS Corp	1,027,596	0	For
Legal & General Investment Management Ltd	0	940,950	Against
Amundi	0	892,319	Against
ORBIMED ADVISORS LLC	872,953	0	For
Aberdeen	744,068	0	For

Showing the 25 largest of 812 asset managers. See all 812 in the interactive database.

2. To approve the Biogen Inc. 2024 Omnibus Plan.

CORPORATE GOVERNANCE

Meeting held 2024-06-20.

Combines 4 wordings of this item as funds reported it.

99% fund support · no official result

FOR 99%

The 148 asset managers below cast 99% of the shares they voted on this item FOR (65,560,269 for, 781,136 against).

FOR: 65,560,269 (98.8%)AGAINST: 781,136 (1.2%)ABSTAIN: 9 (0.0%)

Largest asset managers voting on “To approve the Biogen Inc. 2024 Omnibus Plan.” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	33,429,229	0	For
BlackRock	5,513,351	0	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,877,254	0	For
PRIMECAP Odyssey Funds	2,212,789	0	For
State Street	1,762,869	87	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,823	0	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	0	594,866	Against
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 148 asset managers. See all 148 in the interactive database.

3. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Caroline D. Dorsa

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

74% Majority: yes · of votes cast

FOR 74%AGAINST 26%

FOR: 87,883,981AGAINST: 31,591,984

BIOGEN INC.’s own tally for this item (“Elect Director: Caroline D. Dorsa”): 87,883,981 for, 31,591,984 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 61% for, 22% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 66% of the shares they voted on this item FOR (43,501,570 for, 22,844,611 against).

FOR 66%AGAINST 34%

FOR: 43,501,570 (65.6%)AGAINST: 22,844,611 (34.4%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	15,931,761	17,497,468	Against
BlackRock	5,511,108	2,243	For
T. Rowe Price	3,323,303	897,693	For
Fidelity	3,588,836	288,418	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,672	284	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	0	1,241,920	Against
Invesco	1,126,977	0	For
Jackson National	1,084,731	28,092	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

4. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Christopher A. Viehbacher

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

99.2% Majority: yes · of votes cast

FOR 99.2%

FOR: 118,593,483AGAINST: 886,743

BIOGEN INC.’s own tally for this item (“Elect Director: Christopher A. Viehbacher”): 118,593,483 for, 886,743 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 82% for, 0.7% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (66,345,055 for, 1,125 against).

FOR 99.9%

FOR: 66,345,055 (100.0%)AGAINST: 1,125 (0.0%)ABSTAIN: 15,867 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	33,429,229	0	For
BlackRock	5,512,579	772	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,877,254	0	For
PRIMECAP Odyssey Funds	2,212,789	0	For
State Street	1,762,867	89	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,823	0	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

5. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Eric K. Rowinsky

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%AGAINST 19%

FOR: 96,514,372AGAINST: 22,954,348

BIOGEN INC.’s own tally for this item (“Elect Director: Eric K. Rowinsky”): 96,514,372 for, 22,954,348 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 67% for, 16% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 75% of the shares they voted on this item FOR (49,832,812 for, 16,513,368 against).

FOR 75%AGAINST 25%

FOR: 49,832,812 (75.1%)AGAINST: 16,513,368 (24.9%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	20,490,214	12,939,015	For
BlackRock	5,511,108	2,243	For
T. Rowe Price	3,323,303	897,693	For
Fidelity	3,789,997	87,257	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,672	284	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,410	413	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

6. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Jesus B. Mantas

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST 17%

FOR: 99,615,562AGAINST: 19,856,501

BIOGEN INC.’s own tally for this item (“Elect Director: Jesus B. Mantas”): 99,615,562 for, 19,856,501 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 69% for, 14% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 75% of the shares they voted on this item FOR (49,992,346 for, 16,353,834 against).

FOR 75%AGAINST 25%

FOR: 49,992,346 (75.3%)AGAINST: 16,353,834 (24.6%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	20,490,214	12,939,015	For
BlackRock	5,512,579	772	For
T. Rowe Price	3,323,303	897,693	For
Fidelity	3,789,997	87,257	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,887	69	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,410	413	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

7. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Maria C. Freire

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST 16%

FOR: 100,691,870AGAINST: 18,771,139

BIOGEN INC.’s own tally for this item (“Elect Director: Maria C. Freire”): 100,691,870 for, 18,771,139 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 69% for, 13% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 77% of the shares they voted on this item FOR (51,193,126 for, 15,153,054 against).

FOR 77%AGAINST 23%

FOR: 51,193,126 (77.1%)AGAINST: 15,153,054 (22.8%)ABSTAIN: 15,869 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	20,490,214	12,939,015	For
BlackRock	5,512,579	772	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,877,254	0	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,887	69	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,823	0	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

8. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Monish Patolawala

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

99.6% Majority: yes · of votes cast

FOR 99.6%

FOR: 119,078,211AGAINST: 388,227

BIOGEN INC.’s own tally for this item (“Elect Director: Monish Patolawala”): 119,078,211 for, 388,227 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 82% for, 0.3% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (66,345,947 for, 232 against).

FOR 99.9%

FOR: 66,345,947 (100.0%)AGAINST: 232 (0.0%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Vote
Vanguard	33,429,229	For
BlackRock	5,513,351	For
T. Rowe Price	4,220,996	For
Fidelity	3,877,254	For
PRIMECAP Odyssey Funds	2,212,789	For
State Street	1,762,956	For
VanEck ETF Trust	1,647,240	For
JPMorgan	1,241,920	For
Invesco	1,126,977	For
Jackson National	1,112,823	For
Dimensional	887,791	For
Charles Schwab	855,363	For
Columbia Threadneedle	636,485	For
American Century	594,866	For
Legg Mason	569,667	For
MFS	437,359	For
First Trust	411,978	For
Parnassus	360,742	For
Brown Advisory Funds	351,630	For
TIAA	337,828	For
Voya	297,718	For
Aberdeen	287,651	For
MASTER INVESTMENT PORTFOLIO	227,462	For
Goldman Sachs	192,158	For
ProShares	188,102	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

9. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Stephen A. Sherwin

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

85% Majority: yes · of votes cast

FOR 85%AGAINST 15%

FOR: 101,152,837AGAINST: 18,318,068

BIOGEN INC.’s own tally for this item (“Elect Director: Stephen A. Sherwin”): 101,152,837 for, 18,318,068 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 70% for, 13% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 77% of the shares they voted on this item FOR (51,075,625 for, 15,270,555 against).

FOR 77%AGAINST 23%

FOR: 51,075,625 (77.0%)AGAINST: 15,270,555 (23.0%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	20,490,214	12,939,015	For
BlackRock	5,512,579	772	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,877,254	0	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,801	155	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,823	0	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

10. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: Susan K. Langer

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

78% Majority: yes · of votes cast

FOR 78%AGAINST 22%

FOR: 92,603,948AGAINST: 26,870,919

BIOGEN INC.’s own tally for this item (“Elect Director: Susan K. Langer”): 92,603,948 for, 26,870,919 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 64% for, 19% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 66% of the shares they voted on this item FOR (43,783,640 for, 22,562,540 against).

FOR 66%AGAINST 34%

FOR: 43,783,640 (66.0%)AGAINST: 22,562,540 (34.0%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	15,931,761	17,497,468	Against
BlackRock	5,512,579	772	For
T. Rowe Price	3,323,303	897,693	For
Fidelity	3,588,836	288,418	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,887	69	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	0	1,241,920	Against
Invesco	1,126,977	0	For
Jackson National	1,084,731	28,092	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

11. Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of Directors to serve for a one-year term extending until our 2025 annual meeting of stockholders and their successors are duly elected and qualified: William A. Hawkins

DIRECTOR ELECTIONSMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 7 wordings of this item as funds reported it.

80% Majority: yes · of votes cast

FOR 80%AGAINST 20%

FOR: 95,931,549AGAINST: 23,539,595

BIOGEN INC.’s own tally for this item (“Elect Director: William A. Hawkins”): 95,931,549 for, 23,539,595 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 66% for, 16% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 70% of the shares they voted on this item FOR (46,530,121 for, 19,816,059 against).

FOR 70%AGAINST 30%

FOR: 46,530,121 (70.1%)AGAINST: 19,816,059 (29.9%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “Election of Directors. To elect the 9 nominees identified in the accompanying Proxy Statement to our Board of ” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	15,931,761	17,497,468	Against
BlackRock	5,511,108	2,243	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,864,951	12,303	For
PRIMECAP Odyssey Funds	0	2,212,789	Against
State Street	1,762,759	197	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,823	0	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

12. To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision.

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 6 wordings of this item as funds reported it.

86% Majority: yes · of votes cast

FOR 86%14%

FOR: 103,146,578AGAINST: 16,274,796

BIOGEN INC.’s own tally for this item (“Proposal 4: Stockholders approved the amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an officer exculpation provision, with the votes cast as follows:”): 103,146,578 for, 16,274,796 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 71% for, 11% against (82% of the company cast a for/against vote).

The 146 asset managers below cast 92% of the shares they voted on this item FOR (61,269,484 for, 5,076,693 against).

FOR 92%8%

FOR: 61,269,484 (92.3%)AGAINST: 5,076,693 (7.6%)ABSTAIN: 15,871 (0.0%)

Largest asset managers voting on “To approve an amendment to Biogen's Amended and Restated Certificate of Incorporation, as amended, to add an o” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	33,429,229	0	For
BlackRock	5,509,250	4,101	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,688,396	188,858	For
PRIMECAP Odyssey Funds	2,212,789	0	For
State Street	1,762,869	87	For
VanEck ETF Trust	0	1,647,240	Against
JPMorgan	0	1,241,920	Against
Invesco	1,126,977	0	For
Jackson National	1,085,144	27,679	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	1,562	568,105	Against
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	0	360,742	Against
Brown Advisory Funds	0	351,630	Against
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

13. To approve the Biogen Inc. 2024 Employee Stock Purchase Plan.

CORPORATE GOVERNANCE

Meeting held 2024-06-20.

Combines 4 wordings of this item as funds reported it.

99.9% fund support · no official result

FOR 99.9%

The 146 asset managers below cast 99.9% of the shares they voted on this item FOR (66,326,022 for, 15,212 against).

FOR: 66,326,022 (100.0%)AGAINST: 15,212 (0.0%)ABSTAIN: 5 (0.0%)

Largest asset managers voting on “To approve the Biogen Inc. 2024 Employee Stock Purchase Plan.” at BIOGEN INC., 2023-2024
Asset manager	For	Vote
Vanguard	33,429,229	For
BlackRock	5,513,351	For
T. Rowe Price	4,220,996	For
Fidelity	3,877,254	For
PRIMECAP Odyssey Funds	2,212,789	For
State Street	1,762,956	For
VanEck ETF Trust	1,647,240	For
JPMorgan	1,241,920	For
Invesco	1,126,977	For
Jackson National	1,112,823	For
Dimensional	887,791	For
Charles Schwab	855,363	For
Columbia Threadneedle	636,485	For
American Century	594,866	For
Legg Mason	569,667	For
MFS	437,359	For
First Trust	411,978	For
Parnassus	360,742	For
Brown Advisory Funds	351,630	For
TIAA	337,828	For
Voya	297,718	For
Aberdeen	287,651	For
MASTER INVESTMENT PORTFOLIO	227,462	For
Goldman Sachs	192,158	For
ProShares	188,102	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

14. To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for fiscal year ending December 31, 2024.

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 4 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 123,728,418AGAINST: 5,348,316

BIOGEN INC.’s own tally for this item (“Proposal 2: Stockholders ratified the selection of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, with the votes cast as follows:”): 123,728,418 for, 5,348,316 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 85% for, 4% against (89% of the company cast a for/against vote).

The 146 asset managers below cast 99.8% of the shares they voted on this item FOR (66,216,563 for, 129,617 against).

FOR 99.7%

FOR: 66,216,563 (99.8%)AGAINST: 129,617 (0.2%)ABSTAIN: 15,868 (0.0%)

Largest asset managers voting on “To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
Vanguard	33,429,229	0	For
BlackRock	5,513,351	0	For
T. Rowe Price	4,220,996	0	For
Fidelity	3,877,254	0	For
PRIMECAP Odyssey Funds	2,212,789	0	For
State Street	1,762,869	87	For
VanEck ETF Trust	1,647,240	0	For
JPMorgan	1,241,920	0	For
Invesco	1,126,977	0	For
Jackson National	1,112,823	0	For
Dimensional	887,791	0	For
Charles Schwab	855,363	0	For
Columbia Threadneedle	636,485	0	For
American Century	594,866	0	For
Legg Mason	569,667	0	For
MFS	437,359	0	For
First Trust	411,978	0	For
Parnassus	360,742	0	For
Brown Advisory Funds	351,630	0	For
TIAA	337,828	0	For
Voya	297,718	0	For
Aberdeen	287,651	0	For
MASTER INVESTMENT PORTFOLIO	227,462	0	For
Goldman Sachs	192,158	0	For
ProShares	188,102	0	For

Showing the 25 largest of 146 asset managers. See all 146 in the interactive database.

15. Advisory Vote to Ratify Named Executive Officers' Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-20.

96% Majority: yes · of votes cast

FOR 96%

FOR: 114,367,799AGAINST: 5,054,473

The 32 asset managers below cast 95% of the shares they voted on this item FOR (3,592,773 for, 200,983 against).

FOR 95%

FOR: 3,592,773 (94.7%)AGAINST: 200,983 (5.3%)ABSTAIN: 884 (0.0%)ONE YEAR: 2 (0.0%)

Largest asset managers voting on “Advisory Vote to Ratify Named Executive Officers' Compensation” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
JPMorgan	2,681,924	0	0	For
APG Asset Management US Inc.	158,873	0	0	For
RA CAPITAL MANAGEMENT, L.P.	150,000	0	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	149,258	0	0	For
TD ASSET MANAGEMENT INC	140,680	0	0	For
BANCO BILBAO VIZCAYA ARGENTARIA, S.A.	102,244	0	0	For
NORDEA INVESTMENT MANAGEMENT AB	0	94,039	0	Against
STOREBRAND ASSET MANAGEMENT AS	89,993	0	0	For
Desjardins Global Asset Management Inc.	0	53,310	0	Against
SECTOR GAMMA AS	43,985	0	0	For
Cardano Risk Management B.V.	0	31,333	0	Against
OSSIAM	25,343	0	0	For
Union Investment Privatfonds GmbH	0	21,900	0	Against
Empower	17,317	0	0	For
iA Global Asset Management Inc.	13,658	0	0	For
TOBAM	10,163	0	0	For
Brighthouse	2,258	0	0	For
Rock Point Advisors, LLC	1,840	0	0	For
Tredje AP-fonden	1,838	0	0	For
Symmetry Panoramic Trust	409	0	884	Abstain
CIDEL ASSET MANAGEMENT INC	1,102	0	0	For
Empirical Financial Services, LLC d.b.a. Empirical Wealth Ma	596	0	0	For
Hanson & Doremus Investment Management	525	0	0	For
Convergence Investment Partners, LLC	463	0	0	For
Regime de rentes du Mouvement Desjardins	0	400	0	Against

Showing the 25 largest of 32 asset managers. See all 32 in the interactive database.

16. 14A Executive Compensation

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2024-06-20.

Combines 11 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%

FOR: 114,367,799AGAINST: 5,054,473

The 23 asset managers below cast 100% of the shares they voted on this item FOR (97,419 for, 0 against).

FOR 100%

FOR: 97,419 (100.0%)

Largest asset managers voting on “14A Executive Compensation” at BIOGEN INC., 2023-2024
Asset manager	For	Vote
GRIMES & COMPANY, INC.	44,180	For
Janney Montgomery Scott LLC	21,922	For
Fiera Capital Corp	13,823	For
Ramsay, Stattman, Vela & Price, Inc.	7,545	For
Exome Asset Management LLC	6,400	For
GYL FINANCIAL SYNERGIES, LLC	646	For
Empower	612	For
NAPLES GLOBAL ADVISORS, LLC	610	For
Penobscot Investment Management Company, Inc.	449	For
Parisi Gray Wealth Management	345	For
Argyle Capital Management Inc.	250	For
WHITENER CAPITAL MANAGEMENT, INC.	242	For
Baker Avenue Asset Management, LP	125	For
Signet Investment Advisory Group, Inc.	75	For
Roble, Belko & Company, Inc	50	For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	50	For
Simplify Exchange Traded Funds	34	For
Financial Alternatives, Inc	30	For
Lido Advisors, LLC	21	For
TOWNSEND ASSET MANAGEMENT CORP /NC/ /ADV	6	For
MERCER GLOBAL ADVISORS INC /ADV	4	For
IPConcept (Luxemburg) S.A.	0	--
Port Capital LLC	0	--

17. Approve Omnibus Stock Plan

COMPENSATIONCORPORATE GOVERNANCE

Meeting held 2024-06-20.

99.6% fund support · no official result

FOR 99%

The 10 asset managers below cast 99.6% of the shares they voted on this item FOR (103,795 for, 400 against).

FOR: 103,795 (98.8%)AGAINST: 400 (0.4%)ABSTAIN: 884 (0.8%)

Largest asset managers voting on “Approve Omnibus Stock Plan” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Abstain	Vote
SECTOR GAMMA AS	43,985	0	0	For
OSSIAM	25,343	0	0	For
Empower	17,317	0	0	For
iA Global Asset Management Inc.	13,658	0	0	For
Brighthouse	2,258	0	0	For
Symmetry Panoramic Trust	409	0	884	Abstain
Hanson & Doremus Investment Management	525	0	0	For
Regime de rentes du Mouvement Desjardins	0	400	0	Against
Capitol Series Trust	245	0	0	For
Warren Street Wealth Advisors, LLC	55	0	0	For

18. Approve Qualified Employee Stock Purchase Plan

COMPENSATIONCORPORATE GOVERNANCE

Meeting held 2024-06-20.

100% fund support · no official result

FOR 99%

The 9 asset managers below cast 100% of the shares they voted on this item FOR (78,852 for, 0 against).

FOR: 78,852 (98.9%)ABSTAIN: 884 (1.1%)

Largest asset managers voting on “Approve Qualified Employee Stock Purchase Plan” at BIOGEN INC., 2023-2024
Asset manager	For	Abstain	Vote
SECTOR GAMMA AS	43,985	0	For
Empower	17,317	0	For
iA Global Asset Management Inc.	13,658	0	For
Brighthouse	2,258	0	For
Symmetry Panoramic Trust	409	884	Abstain
Hanson & Doremus Investment Management	525	0	For
Regime de rentes du Mouvement Desjardins	400	0	For
Capitol Series Trust	245	0	For
Warren Street Wealth Advisors, LLC	55	0	For

19. Say on Pay - To hold an advisory vote on executive compensation.

SECTION 14A SAY-ON-PAY VOTESMajority of the votes cast: yes

Meeting held 2025-06-17 (outside the 2023-2024 season's 1 July to 30 June window; reported in this season's filings).

Combines 3 wordings of this item as funds reported it.

68% Majority: yes · of votes cast

FOR 68%AGAINST 32%

FOR: 78,531,756AGAINST: 37,113,368

BIOGEN INC.’s own tally for this item (“Proposal 3: Stockholders approved the advisory vote on executive compensation, with the votes cast as follows:”): 78,531,756 for, 37,113,368 against, per its Form 8-K (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 144,900,000 outstanding shares: 54.2% for, 26% against (80% of the company cast a for/against vote).

The 7 asset managers below cast 100% of the shares they voted on this item FOR (4,320 for, 0 against).

FOR 100%

FOR: 4,320 (100.0%)

Largest asset managers voting on “Say on Pay - To hold an advisory vote on executive compensation.” at BIOGEN INC., 2023-2024
Asset manager	For	Vote
ETF Opportunities Trust	2,185	For
First County Bank /CT/	1,797	For
Argyle Capital Management, LLC	250	For
Freedom Day Solutions, LLC	74	For
Foster Victor Wealth Advisors, LLC	10	For
Meixler Investment Management, Ltd.	3	For
MBA Advisors LLC	1	For

20. Adopt Employee Stock Purchase Plan

COMPENSATIONSHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2024-06-20.

99.8% fund support · no official result

FOR 99.8%

The 3 asset managers below cast 99.8% of the shares they voted on this item FOR (44,214 for, 50 against).

FOR: 44,214 (99.9%)AGAINST: 50 (0.1%)

Largest asset managers voting on “Adopt Employee Stock Purchase Plan” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Vote
GRIMES & COMPANY, INC.	44,180	0	For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	0	50	Against
Simplify Exchange Traded Funds	34	0	For

21. Adopt Omnibus Stock Option Plan

COMPENSATIONSHAREHOLDER RIGHTS AND DEFENSES

Meeting held 2024-06-20.

100% fund support · no official result

FOR 100%

The 3 asset managers below cast 100% of the shares they voted on this item FOR (44,264 for, 0 against).

FOR: 44,264 (100.0%)

Largest asset managers voting on “Adopt Omnibus Stock Option Plan” at BIOGEN INC., 2023-2024
Asset manager	For	Vote
GRIMES & COMPANY, INC.	44,180	For
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	50	For
Simplify Exchange Traded Funds	34	For

22. Approve Article Amendments

CORPORATE GOVERNANCEMajority of the votes cast: yes

Meeting held 2024-06-20.

86% Majority: yes · of votes cast

FOR 86%14%

FOR: 103,146,578AGAINST: 16,274,796

The 2 asset managers below cast 100% of the shares they voted on this item FOR (84 for, 0 against).

FOR 100%

FOR: 84 (100.0%)

Largest asset managers voting on “Approve Article Amendments” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	50	0	0	0	For
Simplify Exchange Traded Funds	34	0	0	0	For

23. Compensation

COMPENSATIONMajority of the votes cast: yes

Meeting held 2024-06-20.

96% Majority: yes · of votes cast

FOR 96%

FOR: 114,367,799AGAINST: 5,054,473

The 2 asset managers below cast 100% of the shares they voted on this item FOR (450 for, 0 against).

FOR 100%

FOR: 450 (100.0%)

Largest asset managers voting on “Compensation” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
Capital Group	250	0	0	0	For
Members Trust Co	200	0	0	0	For

24. Election of Directors (Majority Voting)

DIRECTOR ELECTIONS

Meeting held 2024-06-20.

All nominees (reported as one line). These filers reported the election of directors as a single line covering every nominee. It is not attributed to any one director, and no share total is shown for it.

100% fund support · no official result

FOR 100%

The 2 asset managers below cast 100% of the shares they voted on this item FOR.

FOR: 100.0%

Largest asset managers voting on “Election of Directors (Majority Voting)” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	50	0	0	0	For
Simplify Exchange Traded Funds	34	0	0	0	For

25. Ratify Appointment of Independent Auditors

AUDIT-RELATEDMajority of the votes cast: yes

Meeting held 2024-06-20.

96% Majority: yes · of votes cast

FOR 96%

FOR: 123,728,418AGAINST: 5,348,316

The 2 asset managers below cast 100% of the shares they voted on this item FOR (84 for, 0 against).

FOR 100%

FOR: 84 (100.0%)

Largest asset managers voting on “Ratify Appointment of Independent Auditors” at BIOGEN INC., 2023-2024
Asset manager	For	Against	Abstain	Withheld	Vote
ZIMMERMANN INVESTMENT MANAGEMENT & PLANNING LLC	50	0	0	0	For
Simplify Exchange Traded Funds	34	0	0	0	For

Largest BIOGEN INC. shareholders voting in 2023-2024

Ranked by the number of BIOGEN INC. shares each manager voted on the most widely held ballot item of the 2023-2024 meeting, shown as a share of the 144,900,000 shares outstanding at the time of that meeting.

Top BIOGEN INC. shareholders by shares voted, 2023-2024
#	Asset manager	% of shares outstanding
1	Vanguard	23.51%
2	PRIMECAP MANAGEMENT CO/CA/	10.89%
3	BlackRock	7.97%
4	T. Rowe Price	7.81%
5	State Street	4.09%
6	Wellington	3.46%
7	Fidelity	3.46%
8	GEODE CAPITAL MANAGEMENT, LLC	2.37%
9	Invesco	1.61%
10	PRIMECAP Odyssey Funds	1.53%

Reported BIOGEN INC. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

BIOGEN INC. beneficial owners on record for the 2023-2024 proxy season
Holder	% outstanding	Disclosure
Vanguard Group	11.93%	13F
BlackRock	10.19%	13F
Biogen MA Inc.	4.94%	13G
State Street	4.66%	13F
Wellington Management	3.53%	13F
Geode Capital	2.35%	13F
Morgan Stanley	1.55%	13F
Invesco	1.15%	13F
T. Rowe Price	1.10%	13F
Northern Trust	0.96%	13F

Percentages above are of 144,900,000 shares outstanding, as reported by BIOGEN INC. on its Form 10-K dated 2023-12-31 (see the filing on EDGAR). This is the count contemporaneous with the 2023-2024 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from BIOGEN INC.’s 10-K dated 2023-12-31. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At BIOGEN INC.'s shareholder meeting held 2024-06-20, in the 2023-2024 proxy season, 877 asset managers reported how they voted in their SEC Form N-PX filings, covering 12,275 separate fund positions. Their filings are grouped here into 25 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. On the most widely held item on that ballot — Say on Pay - To hold an advisory vote on executive compensation. — FOR was 96% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: BIOGEN INC.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission (filing date not recorded for this item).

BIOGEN INC. proxy season coverage: 2023-2024 (this page) · 2024-2025 · 2025-2026.